Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580. (Q40947866)
scientific article published on May 1999
Language:
(P31) (Q13442814)
(P304) 191-196
(P407) (Q1860)
(P433) 2
(P478) 451
(P577) Saturday, May 1, 1999
(P1433) (Q1388051)
(P1476) "Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580." (language: en)
(P2093) P A Eyers
P van den IJssel
R A Quinlan
M Goedert
P Cohen
(P2860) (Q36914508)
(Q24311139)
(Q29620495)
(Q24316962)
(Q42468327)
(Q34432656)
(Q27735488)
(Q42541263)
(Q47982160)
(Q42029877)
(Q37651825)
(Q40983592)
(Q24528645)
(Q24319704)
(Q29617438)
(Q34239042)
(Q30452676)
(Q41179859)
(Q58438199)
(Q63408082)
(Q77733964)
other details
description scientific article published on May 1999

External Links